NCT05093881

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Pharmicell Co., Ltd. · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.

Detailed description

To evaluate the safety for 60 months after a single dose of Cellgram-LC in patients with alcoholic liver cirrhosis.

Conditions

• Alcoholic Cirrhosis

Interventions

Type	Name	Description
BIOLOGICAL	Cellgram-LC	Patients who had administered Cellgram-LC in PMC-P-07 study

Timeline

• Start date: 2021-08-24
• Primary completion: 2026-08-24
• Completion: 2028-03-31
• First posted: 2021-10-26
• Last updated: 2024-03-21

Locations

11 sites across 1 country: South Korea